Products for Research Use Only
RegisterLogin

Duvortuxizumab

CAT: 0804-HY-P99868-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99868-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E[1].
CAS Number
1831098-91-9
Product Name Alternative
MGD 011
UNSPSC
12352203
Target
CD19; CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/duvortuxizumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Duvortuxizumab]
Molecular Weight
(145.012 kDa)
References & Citations
[1]Duvortuxizumab. IMGT.|[2]Liu L, et al., MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies. Clin Cancer Res. 2017 Mar 15;23 (6) :1506-1518.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
E40YR1422Duvortuxizumab
GTR18334046Duvortuxizumab Antibody
WA2707Research Grade Duvortuxizumab
E55B1213Duvortuxizumab (Reference antibody)
591807Duvortuxizumab (CD19, CD3E)
KBI1755KRIBIOLISA™ Duvortuxizumab ELISA
GTR18697936-01Duvortuxizumab Human Monoclonal Antibody
10-780Duvortuxizumab (CD19/CD3E) - Research Grade Biosimilar
YR1422-01Anti-Human CD19 & CD3E Recombinant Antibody (Duvortuxizumab)
GTR18118090Duvortuxizumab (CD19/CD3E) - Research Grade Biosimilar Antibody

Popular Products